Dark Forest Capital Management LP Replimune Group, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $66 - $99	5 New	5 $0
Q1 2022 May 13, 2022	SELL	$15.24 - $29.75 $2,682 - $5,236	-176 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$25.43 - $34.25 $227,140 - $305,921	-8,932 Reduced 98.07%	176 $5,000
Q3 2021 Nov 12, 2021	BUY	$28.98 - $39.54 $198,947 - $271,442	6,865 Added 306.06%	9,108 $270,000
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $63,925 - $88,306	2,243 New	2,243 $86,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.